Differential expression of matrix metalloproteinase-9 gene in wounds of type 2 diabetes mellitus cases with susceptible -1562c>t genotypes and wound severity

International Journal of Lower Extremity Wounds

Volumn 13, Issue 2, 2014, Pages 94-102

  Singh, Kiran ^a   Agrawal, Neeraj K ^a   Gupta, Sanjeev K ^a   Mohan, Gyanendra ^b   Chaturvedi, Sunanda ^b   Singh, Kanhaiya ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b Indian Railways Cancer Inst Res C   (India)

Author keywords

diabetic wound healing; epigentics; expression; MMP9

Indexed keywords

GELATINASE B;

ADULT; AMPLICON; ARTICLE; BREAST IMPLANT; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN BIOPSY; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 84902826519     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734614534980     Document Type: Article

References (22)

1. Diegelmann RF, Evans MC. Wound Healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004 ; 9: 283-289
2. Whitney JD. Overview: acute and chronic wounds. Nurs Clin North Am. 2005 ; 40: 191-205
3. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res. 1998 ; 242: 201-210
4. Reiss MJ, Han YP, Garcia E, Goldberg M, Yu H, Garner WL. Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery. 2010 ; 147: 295-302
5. McLennan SV, Min D, Yue DK. Matrix metalloproteinases and their roles in poor wound healing in diabetes. Wound Pract Res. 2009 ; 16: 116-121
6. Agrawal Kanhaiya NK, Gupta SK, Singh K. Differential expression of Toll like receptor 4 in type 2 diabetic patients with impaired wound healing. J Diabetes Metab. 2013 ; 4: 260
7. Singh K, Singh VK, Agrawal NK, Gupta SK, Singh K. Association of toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in the assessment of DFU risk in type 2 diabetes patients. Biomed Res Int. 2013 ; 2013: 318686
8. Singh K, Agrawal NK, Gupta SK, Singh K. Association of variant rs7903146 (C/T) single nucleotide polymorphism of TCF7L2 gene with impairment in wound healing among north Indian type 2 diabetes population: a case-control study. Int J Low Extrem Wounds. 2013 ; 12: 310-315
9. Van den Steen PE, Proost P, Grillet B, et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002 ; 16: 379-389
10. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP9 production by human corneal epithelial cells. Exp Eye Res. 2001 ; 73: 449-459
11. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res. 2009 ; 69: 636-645
12. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999 ; 9: 1788-1794
13. Singh K, Agrawal NK, Gupta SK, Singh K. A functional SNP-1562C>T in the matrix metalloproteinases-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Low Extrem Wounds. 2013 ; 12: 199-204
14. Wagner FW. The dysvascular foot: a system of diagnosis and treatment. Foot Ankle. 1981 ; 2: 64-122
15. Gremlich S, Nguyen D, Reymondin D, et al. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. J Reprod Immunol. 2007 ; 74: 143-151
16. Thompson JES, Webb R, Hewlett P, et al. Matrix metalloproteinase-9 and augmentation index are reduced with an 8-week green-exercise walking programme. J Hypertens. 2013 ; 2: 127
17. Souil E, Capon A, Mordon S, Dinh-Xuan AT, Polla BS, Bachelet M. Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin. Br J Dermatol. 2001 ; 144: 260-266
18. Roach HI, Yamada N, Cheung KS, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005 ; 52: 3110-3124
19. Liu Y, Min D, Bolton T, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009 ; 32: 117-119
20. Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012 ; 61: 2937-2947
21. Medley TL, Cole TJ, Dart AM, Gatzka CD, Kingwell BA. Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol. 2004 ; 24: 1479-1484
22. Blankenberg S, Rupprecht HJ, Poirier O, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003 ; 107: 1579-1585